Lin BioScience, Inc. (6696.TWO)
TWD 139.5
(4.1%)
TWD 139.5
(4.1%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.59 Billion TWD | 94.2% |
| 2022 | 1.85 Billion TWD | 100.61% |
| 2021 | 923.22 Million TWD | -24.25% |
| 2020 | 1.21 Billion TWD | 390.05% |
| 2019 | 248.72 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.5 Billion TWD | 25.3% |
| 2024 Q2 | 4.5 Billion TWD | 0.0% |
| 2023 Q4 | 3.59 Billion TWD | 0.0% |
| 2023 FY | 3.59 Billion TWD | 94.2% |
| 2023 Q3 | 3.59 Billion TWD | 63.61% |
| 2023 Q2 | 2.19 Billion TWD | 0.0% |
| 2023 Q1 | 2.19 Billion TWD | 18.69% |
| 2022 FY | 1.85 Billion TWD | 100.61% |
| 2022 Q4 | 1.85 Billion TWD | 0.0% |
| 2021 FY | 923.22 Million TWD | -24.25% |
| 2020 FY | 1.21 Billion TWD | 390.05% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -1259.013% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -217.215% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -2331.302% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -281.915% |
| NaviFUS Corp. | 490.53 Million TWD | -633.224% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -307.286% |
| TaiRx, Inc. | 833.74 Million TWD | -331.393% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -163.81% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -4789.641% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -117.157% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -2708.908% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | -23.987% |
| AP Biosciences Inc | 890.75 Million TWD | -303.783% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -66.59% |
| RBC Bioscience Corporation | 753.79 Million TWD | -377.152% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | -15.79% |
| EirGenix Inc. | 11.16 Billion TWD | 67.779% |
| Enimmune corporation | 604.82 Million TWD | -494.67% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -715.23% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -102.214% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -1009.593% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 7.632% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 4.606% |
| TCI GENE Inc. | 1.16 Billion TWD | -208.483% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -850.603% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 76.589% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -776.698% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -1094.797% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -555.441% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -806.315% |
| Neith Corporation | 192.15 Million TWD | -1771.801% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -110.044% |
| VBI | 452.1 Million TWD | -695.555% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -73.259% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -205.807% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -210.138% |
| CHO Pharma, Inc. | 3.08 Billion TWD | -16.548% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -579.722% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -1120.962% |
| Visgeneer Inc. | 397.17 Million TWD | -805.574% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -209.692% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -527.548% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -193.438% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -441.086% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -242.388% |
| GlycoNex Incorporation | 1.55 Billion TWD | -131.626% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 57.821% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -169.692% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 9.034% |
| Intech Biopharm Corporation | 2.71 Billion TWD | -32.668% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -380.478% |
| BiOptic Inc. | 613.77 Million TWD | -486.002% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -192.455% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -163.819% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -414.957% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 35.817% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 5.911% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -457.762% |
| Level Biotechnology Inc. | 822.67 Million TWD | -337.199% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 40.966% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -238.672% |
| Acepodia, Inc. | 6.81 Billion TWD | 47.251% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 6.005% |